Axordia Participation in EUR12 Million EU Human Embryonic Stem Cell Consortium
"Axordia will provide the consortium with important technology and scientific expertise and participation in the project will provide the company access to important research by leaders in the field in Europe. The project is important in terms of providing a focal point for further stem cell progress, consolidating the extensive intellectual expertise and enhancing the competitive advantage of the UK and Europe," said Dr V Paul Gerskowitch, CEO of Axordia.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.